A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)
Clinical trial NCT03610048 · TERMINATED
Trial details
- NCT number
- NCT03610048
- Sponsor
- Alkermes, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-09
- Primary completion
- 2020-05-01
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.